| pubmed-article:16800842 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16800842 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
| pubmed-article:16800842 | lifeskim:mentions | umls-concept:C0596402 | lld:lifeskim |
| pubmed-article:16800842 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16800842 | lifeskim:mentions | umls-concept:C0883208 | lld:lifeskim |
| pubmed-article:16800842 | lifeskim:mentions | umls-concept:C0599781 | lld:lifeskim |
| pubmed-article:16800842 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16800842 | pubmed:dateCreated | 2006-7-21 | lld:pubmed |
| pubmed-article:16800842 | pubmed:abstractText | In Hodgkin's lymphoma, F-18-fluoro-deoxy-d-glucose positron emission tomography (FDG-PET) is used for staging and response evaluation after chemotherapy. However, drug-mediated downregulation of glucose uptake in viable Hodgkin's lymphoma cells might limit the use of FDG-PET. | lld:pubmed |
| pubmed-article:16800842 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16800842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16800842 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16800842 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16800842 | pubmed:issn | 0902-4441 | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:KlugeRegineR | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:KörholzDieter... | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:BarthelHenryk... | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:SabriOsamaO | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:BanningUrsula... | lld:pubmed |
| pubmed-article:16800842 | pubmed:author | pubmed-author:Mauz-KörholzC... | lld:pubmed |
| pubmed-article:16800842 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16800842 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:16800842 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16800842 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16800842 | pubmed:pagination | 102-8 | lld:pubmed |
| pubmed-article:16800842 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:meshHeading | pubmed-meshheading:16800842... | lld:pubmed |
| pubmed-article:16800842 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16800842 | pubmed:articleTitle | Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells. | lld:pubmed |
| pubmed-article:16800842 | pubmed:affiliation | Division of Pediatric Hematology and Oncology, Clinic and Policlinic for Children and Adolescents, University of Leipzig, Leipzig, Germany. | lld:pubmed |
| pubmed-article:16800842 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16800842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
